|

Effect of Fiber Supplementation on the Need for Medication With Gestational Diabetes

RECRUITINGN/ASponsored by Eastern Virginia Medical School
Actively Recruiting
PhaseN/A
SponsorEastern Virginia Medical School
Started2025-02-24
Est. completion2026-02-24
Eligibility
Age18 Years – 50 Years
SexFEMALE
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT06867861

Summary

The hypotheses to be tested are 1) Fiber supplementation will decrease the need for medication in patients with gestational diabetes, and 2) Fiber supplementation will decrease adverse maternal and neonatal outcomes in these patients. In this study, the investigators will conduct a randomized controlled trial to limit bias in evaluating these hypotheses.

Eligibility

Age: 18 Years – 50 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Singleton gestation
* Known or new diagnosis of gestational diabetes without reason for medication
* Age \>=18 to \<=50

Exclusion Criteria:

* \- Non-English as primary language.
* Known or suspected fetal anomaly or aneuploidy.
* Known lower bowel disorder
* Known phenylketonuria
* Prisoners.
* Management of diabetes outside of Eastern Virginia Medical School Maternal Fetal Medicine.

Conditions2

DiabetesGestational Diabetes Mellitus (GDM)

Locations1 site

Macon & Joan Brock Virginia Health Sciences at ODU
Norfolk, Virginia, 23507
Morgan Scaglione, MD757-446-7900scaglima@odu.edu

Browse More Trials

Diabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.